FAC MEDICINA
Centro
Broad Institute
Cambridge, Estados UnidosPublicaciones en colaboración con investigadores/as de Broad Institute (14)
2023
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility
PLoS ONE, Vol. 16, Núm. 8
2020
-
The urgent need for integrated science to fight COVID-19 pandemic and beyond
Journal of Translational Medicine, Vol. 18, Núm. 1
2018
-
A community approach to mortality prediction in sepsis via gene expression analysis
Nature Communications, Vol. 9, Núm. 1
-
Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density
Annals of the rheumatic diseases, Vol. 77, Núm. 3, pp. 378-385
2017
-
The FASTK family of proteins: Emerging regulators of mitochondrial RNA biology
Nucleic Acids Research, Vol. 45, Núm. 19, pp. 10941-10947
2013
-
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC
Journal of Experimental Medicine, Vol. 210, Núm. 9, pp. 1807-1821
-
MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: Functional andtherapeutic implications forgeneexpressionand the pathogenesis of hypertension
Human Molecular Genetics, Vol. 22, Núm. 18, pp. 3624-3640